December 15, 2010 | Medtronic has announced the Food and Drug Administration (FDA) approval and the market launch of CareLink Pro 3.0 Therapy Management Software, the first software program to offer advanced decision support to health care professionals managing diabetes.  The software analyzes data from a patient’s insulin pump, continuous glucose monitoring (CGM) device, and blood glucose meter to identify the most important patient information in one easy-to-use dashboard.  In addition, the software offers therapy considerations that clinicians can use as a starting point to discuss therapy changes with their patients to help improve glucose control. Medtronic